Volume 86 Issue 48 | p. 26 | Concentrates
Issue Date: December 1, 2008

Hutchison And Lilly Expand Collaboration

Department: Business

Shanghai-based Hutchison MediPharma and Eli Lilly & Co. have agreed to expand their R&D collaboration. Under the new pact, Lilly will provide another oncology target and Hutchison will assume primary responsibility for the identification and selection of suitable clinical drug candidates. Hutchison will get up-front payments, as well as option fees, milestone payments, and royalties on global sales of any resulting drug. Lilly and Hutchison formed their first such pact in August 2007.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment